Table: diabetes_ndcs_wac_increases_5_year_history , manufacturer_name like S*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

year_str	oshpd_id	manufacturer_name	date_reported	ndc_number	drug_product_description	wac_effective_date	wac_increase_amount	wac_after_increase	patent_expiration_date	drug_source_type	unit_sales_volume_in_us	unit_sales_volume_non_public_indicator	cost_increase_factors	cost_increase_factors_non_public_indicator	change_improvement_description	change_improvement_non_public_indicator	acquisition_date	company_acquired_from	acquisition_price	acquisition_price_non_public_indicator	acquisition_price_comment	wac_at_acquisition	wac_year_prior_to_acquisition	year_drug_introduced_to_market	wac_at_intro_to_market	supporting_documents	general_comments
2019	Rx0000092	Santarus, Inc.	03/31/2019	68012025820	CYCLOSET® (bromocriptine mesytate tablets) 0.8 mg tablets	01/18/2019	47.48	838.74	04/30/2032	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	The product was not acquired within the last 5 years.
2020	Rx0000092	Santarus, Inc.	03/31/2020	68012025820	CYCLOSET (bromocriptine mesytate tablets) 0.8 mg tablets, 200 ct	01/09/2020	50.32	889.06	04/30/2032	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	The product was not acquired within the last 5 years.